Clinical Trials Browser

Arthritis, Joint Diseases

Uterine Cervical Neoplasms

Rhabdomyosarcoma

Colorectal Neoplasms

Cervical Cancer by FIGO Stage 2018

Glioblastoma

Carcinoma, Non-Small-Cell Lung

Glioblastoma

Breast Neoplasms, Triple Negative Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Radiotherapy-induced Oral Mucositis

Squamous Cell Carcinoma of Head and Neck

Rectal Cancer Patients

Triple Negative Breast Neoplasms

Carcinoma, Hepatocellular

Non-Muscle Invasive Bladder Neoplasms

Glioblastoma

Digestive System Neoplasms

Brain Neoplasms, Breast Neoplasms, Meningeal Carcinomatosis

Oropharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Rectal Neoplasms

Nasopharyngeal Carcinoma

Small Cell Lung Carcinoma

Non-Muscle Invasive Bladder Neoplasms

Squamous Cell Carcinoma of Head and Neck

Urinary Bladder Neoplasms, Neoplasms

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Rectal Neoplasms

HER2-Negative Locally Advanced Breast Cancer

Adenocarcinoma, Prostatic Neoplasms

Small Cell Lung Cancer Extensive Stage

Muscle-invasive Bladder Cancer

Small Cell Lung Carcinoma

Lymphoma, B-Cell

Esophageal Neoplasms, Lung Neoplasms, Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Hypoxia, Brain Neoplasms, Glioblastoma

Esophageal Neoplasms

Brain Neoplasms, Breast Neoplasms

Clinical Trials

Radiation to Treat Joint Damage Caused by Cancer Immunotherapy

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

TRIUNITE-07

RETHEMCOL

INSIGHT MRL

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

CURB-TKI

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

NoCUT-BC

Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases

A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

SENTRY

Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC

Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.

Neo-Margin

Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma

TRAIN

NG101m Adjuvant Therapy in Glioblastoma Patients

A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma.

IP rmhTNF-NC + Tislelizumab + Palliat RT for GIT Tumor Malignant Ascites After Failed Std Tx

A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases

Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial

[18F]-AraG PET Imaging in LA HNSCC

STAR

Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma

A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer

RC48 in Combination With Radiotherapy for HER2-Expressing NMIBC Patients

PD-1 Inhibitor Therapy Versus Radiotherapy in MPR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy (HNC-SYSU-006)

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

ZAMBONI

OMEC-5

A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases

NMN

SED-RO-ICC

A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

PCS-XII

TERE

Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W

Low-dose Radiotherapy Combined with Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC

ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT

REPAIR

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer

THREE-GLEES

Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.

Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain Metastases